Gilead Sciences, Inc. - Insider Trading & Ownership

Entity
Company
Location
333 Lakeside Dr, Foster City, CA
Summary
The estimated value of insider holdings of Gilead Sciences, Inc. is at least $824M dollars as of February 20, 2025. Gilead Sciences, Inc. is the 10%+ Owner of Arcellx, Inc. and owns shares of Arcellx, Inc. (ACLX) stock worth about $371M. Gilead Sciences, Inc. is the 10%+ Owner of Arcus Biosciences, Inc. and owns shares of Arcus Biosciences, Inc. (RCUS) stock worth about $346M. Gilead Sciences, Inc. is the 10%+ Owner of ASSEMBLY BIOSCIENCES, INC. and owns shares of ASSEMBLY BIOSCIENCES, INC. (ASMB) stock worth about $47.2M. Gilead Sciences, Inc. is the 10%+ Owner of Xilio Therapeutics, Inc. and owns shares of Xilio Therapeutics, Inc. (XLO) stock worth about $19.8M. Gilead Sciences, Inc. is the 10%+ Owner of LEAP THERAPEUTICS, INC. and owns shares of LEAP THERAPEUTICS, INC. (LPTX) stock worth about $15.2M. Gilead Sciences, Inc. is the 10%+ Owner of HOOKIPA Pharma Inc. and owns shares of HOOKIPA Pharma Inc. (HOOK) stock worth about $13.6M. Gilead Sciences, Inc. is the 10%+ Owner of Allovir, Inc. and owns shares of Kalaris Therapeutics, Inc. (KLRS) stock worth about $11.2M.
All Insider Reports
All Insider Reports

Ownership of Gilead Sciences, Inc.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ACLX Arcellx, Inc. 10%+ Owner $371M Dec 28, 2023
RCUS Arcus Biosciences, Inc. 10%+ Owner $346M +$15M +4.54% Feb 18, 2025
ASMB ASSEMBLY BIOSCIENCES, INC. 10%+ Owner $47.2M +$20.1M +74.1% Dec 19, 2024
XLO Xilio Therapeutics, Inc. 10%+ Owner $19.8M +$8.17M +69.9% Dec 18, 2024
LPTX LEAP THERAPEUTICS, INC. 10%+ Owner $15.2M Apr 10, 2024
HOOK HOOKIPA Pharma Inc. 10%+ Owner $13.6M Dec 20, 2023
KLRS Kalaris Therapeutics, Inc. 10%+ Owner $11.2M Jun 27, 2023
KYTX Kyverna Therapeutics, Inc. 10%+ Owner Feb 12, 2024

Insider Transactions Reported by Gilead Sciences, Inc.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.